Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

Pharma Goes Digital; GMP Compliance Will Never Be the Same

A major shift is underway in pharmaceutical manufacturing as companies move toward hybrid cloud infrastructure, advanced analytics, and digital quality systems. Speaking on the industry's evolving landscape, Mike Hennessy Jr. of MJH Life Sciences highlighted how hybrid cloud architectures, statistical
  • News
Pharma Goes Digital; GMP Compliance Will Never Be the Same

China Biotech Forces Pharma Power Shift; $10B Pfizer Deal Marks Turning Point

Pfizer’s $10 billion licensing deal with Innovent, alongside rising U.S. debate over expanding COINS Act restrictions on China biotech investment, signals a structural shift in global pharma strategy. The announcement, combined with Astellas’ Xtandi patent cliff response and ASCO scrutiny
  • News
China Biotech Forces Pharma Power Shift; $10B Pfizer Deal Marks Turning Point

SOP Checklist in 2026: Red Flags Found During GMP Audits

This article explains how SOP Checklist failures influence GMP inspection outcomes and how structured compliance systems improve audit readiness. It highlights real inspection patterns, document control gaps, and practical strategies to strengthen pharmaceutical quality system performance.
  • Blog, Quality Management System
GMP inspection readiness checklist in pharmaceutical laboratory showing SOP compliance pharma workflow, document control, and audit preparation under quality system standards.

Pharma Shifts From Validation to Speed; What Changed Behind It

As development timelines shrink across the pharmaceutical industry, companies are placing greater emphasis on speed, scalability and manufacturing certainty. The trend, highlighted at CPHI Japan 2026, signals mounting pressure on drugmakers and CDMOs to deliver faster without compromising GMP compliance,
  • News
Pharma Shifts From Validation to Speed; What Changed Behind It

FDA One-Day Inspections Trigger Compliance Shock; AI Shift Reshapes Global Pharma Oversight

FDA launches one-day inspections and expands AI systems Elsa 4.0 and HALO at its headquarters in the United States, introducing a major shift in global pharmaceutical regulation. The move accelerates risk-based oversight and structured-data review, reshaping GMP expectations for manufacturers
  • News
FDA One-Day Inspections Trigger Compliance Shock; AI Shift Reshapes Global Pharma Oversight

ASCO 2026 CAR-T Breakthrough Expands Scale, Don’t Miss This GMP Shift

At ASCO 2026 in Chicago, ASCO 2026, Wondercel Therapeutics, founder Frank Fan, also the inventor of Carvykti, presented early clinical and manufacturing data on a novel allogeneic CAR-T cell therapy platform called Revo-U. The approach aims to overcome key GMP
  • News
ASCO 2026 CAR-T Breakthrough Expands Scale, Don’t Miss This GMP Shift

Eli Lilly Tops Pharma Innovation ;While Pfizer Unexpectedly Falls Behind

Idea Pharma’s 2026 Global Innovation and Invention Index, released this week, shows a clear shift in global pharma leadership. Eli Lilly takes the top position in both innovation and invention, while Pfizer continues to decline after its post-COVID peak. The
  • News
Eli Lilly Tops Pharma Innovation ;While Pfizer Unexpectedly Falls Behind

CAPA Documentation in 2026: Step-by-Step Process, GMP Requirements, and Compliance Best Practices

This Article explains the structured CAPA workflow in quality management system, focusing on documentation elements required for GMP inspection readiness. It highlights how pharmaceutical teams ensure compliance through systematic deviation handling and controlled quality assurance processes.
  • Blog, Quality Management System
Circular diagram showing CAPA report format GMP elements including deviation record, root cause analysis pharmaceutical GMP, corrective actions, and effectiveness checks for audit readiness.